vs
Side-by-side financial comparison of FGI Industries Ltd. (FGI) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $30.5M, roughly 1.9× FGI Industries Ltd.). FGI Industries Ltd. runs the higher net margin — -8.6% vs -246.8%, a 238.1% gap on every dollar of revenue. On growth, Vanda Pharmaceuticals Inc. posted the faster year-over-year revenue change (7.6% vs -14.4%). FGI Industries Ltd. produced more free cash flow last quarter ($2.3M vs $-29.5M). Over the past eight quarters, Vanda Pharmaceuticals Inc.'s revenue compounded faster (9.8% CAGR vs -0.5%).
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
FGI vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.5M | $57.2M |
| Net Profit | $-2.6M | $-141.2M |
| Gross Margin | 26.7% | — |
| Operating Margin | -2.2% | -70.5% |
| Net Margin | -8.6% | -246.8% |
| Revenue YoY | -14.4% | 7.6% |
| Net Profit YoY | -553.1% | -2774.3% |
| EPS (diluted) | $-1.63 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.5M | $57.2M | ||
| Q3 25 | $35.8M | $56.3M | ||
| Q2 25 | $31.0M | $52.6M | ||
| Q1 25 | $33.2M | $50.0M | ||
| Q4 24 | $35.6M | $53.2M | ||
| Q3 24 | $36.1M | $47.7M | ||
| Q2 24 | $29.4M | $50.5M | ||
| Q1 24 | $30.8M | $47.5M |
| Q4 25 | $-2.6M | $-141.2M | ||
| Q3 25 | $-1.7M | $-22.6M | ||
| Q2 25 | $-1.2M | $-27.2M | ||
| Q1 25 | $-629.1K | $-29.5M | ||
| Q4 24 | $-402.3K | $-4.9M | ||
| Q3 24 | $-550.1K | $-5.3M | ||
| Q2 24 | $163.6K | $-4.5M | ||
| Q1 24 | $-412.2K | $-4.1M |
| Q4 25 | 26.7% | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | 28.1% | — | ||
| Q1 25 | 26.8% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 30.5% | — | ||
| Q1 24 | 27.4% | — |
| Q4 25 | -2.2% | -70.5% | ||
| Q3 25 | 1.0% | -55.6% | ||
| Q2 25 | -2.7% | -73.2% | ||
| Q1 25 | -3.9% | -82.0% | ||
| Q4 24 | -3.5% | -19.3% | ||
| Q3 24 | -0.2% | -23.1% | ||
| Q2 24 | -1.5% | -20.1% | ||
| Q1 24 | -1.0% | -19.5% |
| Q4 25 | -8.6% | -246.8% | ||
| Q3 25 | -4.6% | -40.1% | ||
| Q2 25 | -4.0% | -51.7% | ||
| Q1 25 | -1.9% | -58.9% | ||
| Q4 24 | -1.1% | -9.2% | ||
| Q3 24 | -1.5% | -11.2% | ||
| Q2 24 | 0.6% | -9.0% | ||
| Q1 24 | -1.3% | -8.7% |
| Q4 25 | $-1.63 | $-2.40 | ||
| Q3 25 | $-0.86 | $-0.38 | ||
| Q2 25 | $-0.64 | $-0.46 | ||
| Q1 25 | $-0.07 | $-0.50 | ||
| Q4 24 | $-0.38 | $-0.09 | ||
| Q3 24 | $-0.29 | $-0.09 | ||
| Q2 24 | $0.08 | $-0.08 | ||
| Q1 24 | $-0.04 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $17.3M | $327.2M |
| Total Assets | $69.5M | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9M | $84.9M | ||
| Q3 25 | $1.9M | $70.0M | ||
| Q2 25 | $2.5M | $81.0M | ||
| Q1 25 | $1.2M | $111.8M | ||
| Q4 24 | $4.6M | $102.3M | ||
| Q3 24 | $3.0M | $100.5M | ||
| Q2 24 | $1.3M | $103.0M | ||
| Q1 24 | $3.3M | $125.2M |
| Q4 25 | $17.3M | $327.2M | ||
| Q3 25 | $19.7M | $466.0M | ||
| Q2 25 | $21.3M | $486.3M | ||
| Q1 25 | $21.8M | $511.4M | ||
| Q4 24 | $22.3M | $538.5M | ||
| Q3 24 | $23.5M | $541.2M | ||
| Q2 24 | $23.8M | $542.5M | ||
| Q1 24 | $23.9M | $544.0M |
| Q4 25 | $69.5M | $488.9M | ||
| Q3 25 | $73.0M | $601.1M | ||
| Q2 25 | $71.7M | $624.7M | ||
| Q1 25 | $68.5M | $631.9M | ||
| Q4 24 | $75.5M | $656.2M | ||
| Q3 24 | $74.7M | $645.1M | ||
| Q2 24 | $69.9M | $651.4M | ||
| Q1 24 | $68.6M | $652.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $-29.4M |
| Free Cash FlowOCF − Capex | $2.3M | $-29.5M |
| FCF MarginFCF / Revenue | 7.5% | -51.6% |
| Capex IntensityCapex / Revenue | 0.2% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-212.5K | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $-29.4M | ||
| Q3 25 | $-1.9M | $-31.6M | ||
| Q2 25 | $7.6M | $-15.3M | ||
| Q1 25 | $-7.4M | $-33.1M | ||
| Q4 24 | $617.4K | $-1.8M | ||
| Q3 24 | $-915.0K | $-14.6M | ||
| Q2 24 | $862.1K | $-6.9M | ||
| Q1 24 | $-8.0M | $7.6M |
| Q4 25 | $2.3M | $-29.5M | ||
| Q3 25 | $-2.1M | $-31.8M | ||
| Q2 25 | $7.4M | $-15.6M | ||
| Q1 25 | $-7.7M | $-33.6M | ||
| Q4 24 | $-214.1K | $-2.0M | ||
| Q3 24 | $-1.1M | $-14.7M | ||
| Q2 24 | $281.5K | $-7.0M | ||
| Q1 24 | $-8.6M | $7.6M |
| Q4 25 | 7.5% | -51.6% | ||
| Q3 25 | -5.9% | -56.5% | ||
| Q2 25 | 23.8% | -29.6% | ||
| Q1 25 | -23.3% | -67.1% | ||
| Q4 24 | -0.6% | -3.8% | ||
| Q3 24 | -3.0% | -30.9% | ||
| Q2 24 | 1.0% | -13.9% | ||
| Q1 24 | -28.0% | 15.9% |
| Q4 25 | 0.2% | 0.2% | ||
| Q3 25 | 0.7% | 0.3% | ||
| Q2 25 | 0.7% | 0.6% | ||
| Q1 25 | 1.1% | 0.9% | ||
| Q4 24 | 2.3% | 0.4% | ||
| Q3 24 | 0.5% | 0.3% | ||
| Q2 24 | 2.0% | 0.2% | ||
| Q1 24 | 2.0% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.27× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
